Turn Biotechnologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Turn Biotechnologies's estimated annual revenue is currently $5.9M per year.(i)
  • Turn Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Turn Biotechnologies has 38 Employees.(i)
  • Turn Biotechnologies grew their employee count by -5% last year.

Turn Biotechnologies's People

NameTitleEmail/Phone
1
Founder, Scientific Advisory Board ChairReveal Email/Phone
2
Associate VPReveal Email/Phone
3
CEOReveal Email/Phone
4
VP, Strategic PartnershipsReveal Email/Phone
5
Head ImmunologyReveal Email/Phone
6
VP, Intellectual Property and LegalReveal Email/Phone
7
EVP, Fharm Development & CMCReveal Email/Phone
8
Head ResearchReveal Email/Phone
9
Director, CMC ChemistryReveal Email/Phone
10
Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Turn Biotechnologies?

Aging has been called “the emperor of all maladies.” Turn Bio's goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks. Join us as we embark on the task to "turn back time."

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Turn Biotechnologies News

2022-04-06 - Global pharma organizations back Turn Biotechnologies to ...

Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA platform technology,...

2022-04-06 - Astellas-backed Turn Bio is Advancing Epigenetics for Long ...

Turn Biotechnologies announced Monday morning that it has closed an ... Turn Bio's platform is based on using mRNA technology to develop...

2022-04-06 - HanAll Biopharma and Daewoong Pharmaceutical Invest in ...

Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA platform technology,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M38N/AN/A
#2
$4.4M380%N/A
#3
$3.5M39-33%N/A
#4
N/A398%N/A
#5
$7.3M39-2%N/A